GC34106
NSC139021 (ERGi-USU)
Also known as 1-(1,3-thiazol-2-yldiazenyl)naphthalen-2-ol
NSC139021 (ERGi-USU) (ERGi-USU) is a highly selective inhibitor for the growth of ERG-positive cancer cells with IC50s ranging from 30 to 400 nM
ChemicalCAS1147-56-4MW255.3FormulaC13H9N3OS
- CAS number
- 1147-56-4
- Molecular weight
- 255.3
- Formula
- C13H9N3OS
- Solubility
- DMSO ： ≥ 62 mg/mL (242·85 mM)
- InChIKey
- IOMXCGDXEUDZAK-UHFFFAOYSA-N
- Catalogue number
- GC34106
- Brand
- GLPBIO
Computed properties PubChem CID 93572 · XLogP 4 · TPSA 86.1 Ų · H-bond donors 1
- XLogP
- 4
- TPSA
- 86.1 Ų
- H-bond donors
- 1
- H-bond acceptors
- 5
- Rotatable bonds
- 2
- Heavy atoms
- 18
SMILES C1=CC=C2C(=C1)C=CC(=C2N=NC3=NC=CS3)O
Computed descriptors from PubChem (CID 93572), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il